Literature DB >> 7235946

Hypercalcemia in patients with breast cancer. Osseous metastases, hyperplastic parathyroid tissue, or pseudohyperparathyroidism?

R C Hickey, N A Samaan, G L Jackson.   

Abstract

Breast cancer is the malignant neoplasm most commonly associated with hypercalcemia. At the University of Texas M. D. Anderson Hospital, Houston, during the fiscal year 1977 to 1978, of 16,887 patients having calcium determinations, 7.8% had hypercalcemia. From 1969 to 1979, 13 patients had proved and three had presumed primary hyperparathyroidism associated with breast cancer. Two other patients had pseudohyperparathyroidism. Selective neck vein catheterization was used in 17 of the 18 patients and helped localize and confirm the diagnosis of primary hyperparathyroidism. Chloride-phosphate ratios were elevated in 13 of the 14 patients with proved or presumed primary hyperparathyroidism. This condition may mimic osseous metastases by producing brown tumors or compression fractures. In patients with breast cancer and hypercalcemia, particularly without osseous metastases, a careful diagnostic evaluation is warranted to rule out primary hyperparathyroidism.

Entities:  

Mesh:

Year:  1981        PMID: 7235946     DOI: 10.1001/archsurg.1981.01380170035006

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Is the risk of primary hyperparathyroidism increased in patients with untreated breast cancer?

Authors:  V Belardi; E Fiore; E Giustarini; I Muller; S Sabatini; V Rosellini; E Seregni; R Agresti; C Marcocci; P Vitti; C Giani
Journal:  J Endocrinol Invest       Date:  2012-08-29       Impact factor: 4.256

2.  Hypercalcaemia in breast cancer patients: not always bony metastases.

Authors:  Sophie H A Summers; Fung Joon Foo; Sadagopan Varadarajan
Journal:  BMJ Case Rep       Date:  2009-06-01

3.  Mechanism of malignant hypercalcaemia in carcinoma of the breast.

Authors:  R C Percival; A J Yates; R E Gray; J Galloway; K Rogers; F E Neal; J A Kanis
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.